# A Short Term Pharmacokinetic, Pharmacodynamic and Tolerability Study to Compare AOP200704 vs. Esmolol

> **NCT01313143** · PHASE2 · COMPLETED · sponsor: **AOP Orphan Pharmaceuticals AG** · enrollment: 16 (actual)

## Conditions studied

- Healthy Volunteers
- Pharmacokinetics/Dynamics Study

## Interventions

- **DRUG:** AOP200704
- **DRUG:** Esmolol hydrochloride, infusion

## Key facts

- **NCT ID:** NCT01313143
- **Lead sponsor:** AOP Orphan Pharmaceuticals AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2011-05
- **Final completion:** 2012-01
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2012-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01313143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01313143, "A Short Term Pharmacokinetic, Pharmacodynamic and Tolerability Study to Compare AOP200704 vs. Esmolol". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01313143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*